Development of a Gadolinium–Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy-Reference-Cited by-同舟云学术

Development of a Gadolinium–Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy

Published:2023-11-01 Issue:12 Volume:20 Page:6311-6318
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Okada Satoshi¹²^ORCID,Nishimura Kai²,Ainaya Qarri²,Shiraishi Kouichi³,Anufriev Sergey A.⁴,Sivaev Igor B.⁴^ORCID,Sakurai Yoshinori⁵^ORCID,Suzuki Minoru⁵^ORCID,Yokoyama Masayuki³^ORCID,Nakamura Hiroyuki¹²^ORCID

Affiliation:

1. Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsuta, Midori, Yokohama, Kanagawa 226-8503, Japan

2. School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsuta, Midori, Yokohama, Kanagawa 226-8503, Japan

3. Division of Medical Engineering, Research Center for Medical Sciences, The Jikei University School of Medicine, 163-1 Kashiwashita, Kashiwa, Chiba 277-8567, Japan

4. A.N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilov Str., 119334 Moscow, Russia

5. Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2-1010 Asashiro-nishi, Kumatori, Sennan, Osaka 590-0494, Japan

Funder

Russian Foundation for Basic Research

Japan Society for the Promotion of Science

Japan Science and Technology Agency

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00726